Home > New potent synthetic opioid— N-Desethyl Isotonitazene —proliferating among recreational drug supply in USA.

Krotulski, Alex J and Shinefield, Jennifer and Teixeira da Silva, Daniel and Mohr, Amanda L A and DeBord, Joshua and Walton, Sara E and Logan, Barry K (2023) New potent synthetic opioid— N-Desethyl Isotonitazene —proliferating among recreational drug supply in USA. United States: Center for Forensic Science Research and Education.

[img]
Preview
PDF (New potent synthetic opioid—N-Desethyl Isotonitazene)
999kB

N-Desethyl isotonitazene is a new synthetic opioid bearing structural resemblance to isotonitazene and recently emergent nitazene analogues. N-Desethyl isotonitazene is dissimilar in chemical structure to fentanyl, the synthetic opioid most commonly encountered, but this subclass of new opioids has been proliferating in the wake of the scheduling of fentanyl analogues. N-Desethyl isotonitazene is a known metabolite of isotonitazene; however, it has now emerged as a primary drug in its own right. Most nitazene analogues encountered retain opioid receptor activity and potency similar to or greater than fentanyl. In vitro pharmacological data show that N-desethyl isotonitazene is an active opioid agonist and is approximately 20x more potent than fentanyl. In December 2022, N-desethyl isotonitazene was first reported by NPS Discovery (Florida); however, first identifications were observed as early as September 2022. To date, seven drug material samples (“dope” powders) collected from the Philadelphia drug supply have tested positive for N-desethyl isotonitazene. In December 2022, the Philadelphia Department of Public Health issued an alert regarding the discovery of this new nitazene analogue in the city’s drug supply. The toxicity of N-desethyl isotonitazene has not been examined or reported but recent association with overdoses among people who use drugs leads professionals to believe this synthetic opioid has the potential to cause harm and is of high public health concern.

Item Type
Report
Publication Type
International, Report
Drug Type
Opioid, New psychoactive substance
Intervention Type
Harm reduction, Screening / Assessment
Date
January 2023
Pages
1 p.
Publisher
Center for Forensic Science Research and Education
Place of Publication
United States
EndNote
Related (external) link

Repository Staff Only: item control page